Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1988-7-25
pubmed:abstractText
Transfection of deleted forms of the human interleukin 2 receptor alpha subunit (IL-2R alpha; also called CD25 or Tac antigen) gene (IL2RA) promoter revealed a requirement for sequences 3' of base -317 for phytohemagglutinin- and phorbol 12-myristate 13-acetate (PMA)-induced promoter activation in CD4+ Jurkat T cells. In contrast, sequences 3' of base -271 were sufficient for promoter induction in CD4-/CD8- YT-1 T cells or Jurkat cells expressing the transactivator protein (tat-I) of human T-cell lymphotropic virus type I (HTLV-I). Gel retardation assays revealed that nuclear extracts from induced, but not uninduced, Jurkat and YT-1 cells mediated the formation of two specific DNA-protein complexes with oligonucleotides spanning the region of the IL2RA promoter from position -291 to -245, which contains two imperfect direct repeats (IDRs). Consistent with the different 5' sequence requirements for promoter activation in Jurkat and YT-1 cells, oligonucleotides corresponding to the region from -267 to -243 (downstream IDR and flanking region) formed only one complex with induced Jurkat extracts but two complexes with induced YT-1 extracts. Oligonucleotides containing the region of the IL2RA promoter from -293 to -270 (upstream IDR and flanking region) failed to bind protein in either cell type. In further support of the biological significance of these DNA-protein interactions, the IL2RA oligonucleotide from -291 to -245 proved to be sufficient in either orientation to confer PMA inducibility to the mitogen-insensitive thymidine kinase gene promoter in Jurkat cells. Together, these findings suggest that the interaction of inducible DNA binding proteins with the IL2RA promoter between bases -291 and -245 plays an important role in mitogen-induced changes in the transcriptional activity of this receptor gene. Furthermore, the requisite 5' sequences appear to differ in T cells depending upon the nature of the activation signal and perhaps the stage of cellular maturation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-2413364, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-2418464, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-2437143, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-2578514, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-2938741, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-2996141, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3005464, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3011033, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3023889, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3024966, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3026643, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3029959, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3030566, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3031040, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3031660, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3037548, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3040856, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3091480, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3095922, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3098894, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3099289, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3108674, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3116143, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-3116145, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-4041012, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6088625, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6092466, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6098465, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6269744, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6313230, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6443342, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6606011, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6815536, http://linkedlifedata.com/resource/pubmed/commentcorrection/3132714-6960240
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4468-72
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation.
pubmed:affiliation
Howard Hughes Medical Institute, Department of Medicine, Duke University Medical Center, Durham 27710.
pubmed:publicationType
Journal Article